(Q33705868)

28 July 2017

1 reference

title

Homocysteine and vascular disease (English)

1 reference

28 July 2017

1 reference

G J Hankey

1 reference

28 July 2017

J W Eikelboom

1 reference

28 July 2017

language of work or name

English

0 references

publication date

1 July 1999

1 reference

28 July 2017

1 reference

28 July 2017

volume

354

1 reference

28 July 2017

issue

9176

1 reference

28 July 2017

page(s)

407-413

1 reference

Modeling of risk factors for ischemic stroke. The Willis Lecture

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2911058-9

7 January 2021

Disordered methionine/homocysteine metabolism in premature vascular disease. Its occurrence, cofactor therapy, and enzymology

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2911058-9

7 January 2021

ACP Broadsheet No 152: March 1998. Clinical implications of plasma homocysteine measurement in cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2911058-9

7 January 2021

Assessment of homocysteine status

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2911058-9

7 January 2021

The metabolism of homocysteine: pathways and regulation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2911058-9

7 January 2021

Biochemistry and molecular genetics of cystathionine beta-synthase deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2911058-9

7 January 2021

Remethylation defects: guidelines for clinical diagnosis and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2911058-9

7 January 2021

A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2911058-9

7 January 2021

The effects of folic acid supplementation on plasma total homocysteine are modulated by multivitamin use and methylenetetrahydrofolate reductase genotypes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2911058-9

7 January 2021

Vitamin status and intake as primary determinants of homocysteinemia in an elderly population

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2911058-9

7 January 2021

Homocysteinemia due to folate deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2911058-9

7 January 2021

Hyperhomocysteinemia in end-stage renal disease: Prevalence, etiology, and potential relationship to arteriosclerotic outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2911058-9

7 January 2021

Sensitivity of serum methylmalonic acid and total homocysteine determinations for diagnosing cobalamin and folate deficiencies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2911058-9

7 January 2021

Plasma concentrations of homocysteine and other aminothiol compounds are related to food intake in healthy human subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2911058-9

7 January 2021

Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2911058-9

7 January 2021

Major lifestyle determinants of plasma total homocysteine distribution: the Hordaland Homocysteine Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2911058-9

7 January 2021

Plasma homocysteine in the acute and convalescent phases after stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2911058-9

7 January 2021

Serial measures of plasma homocyst(e)ine after acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2911058-9

7 January 2021

Homocysteine and vascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2911058-9

7 January 2021

Reduction of plasma homocyst(e)ine levels by breakfast cereal fortified with folic acid in patients with coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2911058-9

7 January 2021

The pathogenesis of coronary artery disease. A possible role for methionine metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2911058-9

7 January 2021

Homocysteine and ischemic heart disease: results of a prospective study with implications regarding prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2911058-9

7 January 2021

Serum total homocysteine and coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2911058-9

7 January 2021

Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2911058-9

7 January 2021

Plasma homocysteine levels and mortality in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2911058-9

7 January 2021

A prospective study of folate and vitamin B6 and risk of myocardial infarction in US physicians

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2911058-9

7 January 2021

Plasma total homocysteine and risk of angina pectoris with subsequent coronary artery bypass surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2911058-9

7 January 2021

A prospective study of plasma homocyst(e)ine and risk of ischemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2911058-9

7 January 2021

Homocyst(e)ine and Risk of Cardiovascular Disease in the Multiple Risk Factor Intervention Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2911058-9

7 January 2021

Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population based study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2911058-9

7 January 2021

Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins: the Atherosclerosis Risk in Communities (ARIC) study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2911058-9

7 January 2021

A Quantitative Assessment of Plasma Homocysteine as a Risk Factor for Vascular Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2911058-9

7 January 2021

Higher Plasma Homocyst(e)ine and Increased Susceptibility to Adverse Effects of Low Folate in Early Familial Coronary Artery Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2911058-9

7 January 2021

Homocysteine and coronary artery disease in French Canadian subjects: relation with vitamins B12, B6, pyridoxal phosphate, and folate

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2911058-9

7 January 2021

Hyperhomocysteinemia and low pyridoxal phosphate. Common and independent reversible risk factors for coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2911058-9

7 January 2021

Plasma homocyst(e)ine levels and graded risk for myocardial infarction: findings in two populations at contrasting risk for coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2911058-9

7 January 2021

A Common Polymorphism in the Methylenetetrahydrofolate Reductase Gene, Homocysteine, and Ischemic Cerebrovascular Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2911058-9

7 January 2021

Carotid artery intimal-medial wall thickening and plasma homocyst(e)ine in asymptomatic adults. The Atherosclerosis Risk in Communities Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2911058-9

7 January 2021

Association between Plasma Homocysteine Concentrations and Extracranial Carotid-Artery Stenosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2911058-9

7 January 2021

Plasma total homocysteine, B vitamins, and risk of coronary atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2911058-9

7 January 2021

Plasma homocysteine and the extent of atherosclerosis in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2911058-9

7 January 2021

Correlation between plasma homocyst(e)ine and aortic atherosclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2911058-9

7 January 2021

Plasma homocysteine and severity of atherosclerosis in young patients with lower-limb atherosclerotic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2911058-9

7 January 2021

Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease: the result of a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2911058-9

7 January 2021

Meta-analysis of hyperhomocysteinemia as a risk factor for venous thromboembolic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2911058-9

7 January 2021

Interrelation of hyperhomocyst(e)inemia, factor V Leiden, and risk of future venous thromboembolism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2911058-9

7 January 2021

Plasma homocysteine as a risk factor for atherothrombotic events in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2911058-9

7 January 2021

Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2911058-9

7 January 2021

Hyperhomocyst(e)inemia and atherothrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2911058-9

7 January 2021

Eat right and take a multivitamin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2911058-9

7 January 2021

Vitamin supplementation reduces blood homocysteine levels: a controlled trial in patients with venous thrombosis and healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2911058-9

7 January 2021

The natural history of vascular disease in homocystinuria and the effects of treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2911058-9

7 January 2021

Vitamins and progression of atherosclerosis in hyper-homocyst(e)inaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2911058-9

7 January 2021

Homocysteine, vitamins, and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2911058-9

7 January 2021

Homocysteine and coronary atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2911058-9

7 January 2021

Homocysteine, folate, vitamin B6, and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2911058-9

7 January 2021

Homocysteine and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2911058-9

7 January 2021

Hyperhomocysteinemia and Atherosclerotic Vascular Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2911058-9

7 January 2021

Homocysteine and atherothrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2911058-9

7 January 2021

10.1016/S0140-6736(98)11058-9

Identifiers

DOI

1 reference

28 July 2017

1 reference